Maine announces settlement to reduce insulin costs
Under the settlement, Mainers who are uninsured or have commercial health insurance will be eligible to purchase monthly ...
BioSpace12d
Novo, Sanofi Hit With Anti-Competitive Probe in South Africa: Bloomberg
The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...
South African watchdog probes Novo Nordisk and Sanofi over insulin
South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
pharmaphorum3d
Sanofi in final stages of negotiation in sale of generics arm Zentiva
Sanofi is in the final stages of selling its European generics business, Zentiva, to private equity firm Advent International. The companies have signed a share purchase agreement valued at €1.9 ...
Medical Xpress26d
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
Drug Store News27d
Sanofi nears selling 50% controlling stake in Opella to CD&R
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton Dublilier & Rice, known as CD&R. The two companies shared that they have ...